AVXL US Equity
Anavex Life Sciences Corp.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1314052 · FY ends Sep 30$3.39
+0.19 (+5.94%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 14.4M |
| % of shares out | 15.6% |
| Days to cover | 14.4 |
| Δ vs 2026-07-15 | +2.0% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 14,426,670 | +2.0% | 999,855 | 14.4 |
| 2026-07-15 | 14,140,060 | -0.6% | 906,508 | 15.6 |
| 2026-06-30 | 14,228,756 | -18.8% | 2,072,061 | 6.9 |
| 2026-06-15 | 17,526,141 | -7.0% | 1,150,859 | 15.2 |
| 2026-05-29 | 18,834,525 | -2.1% | 1,132,384 | 16.6 |
| 2026-05-15 | 19,232,245 | +1.2% | 980,251 | 19.6 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
